The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Three-Year Surveillance of Community-AcquiredStaphylococcus aureus Infections in Children
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) isolates are increasingly frequent causes of skin and soft-tissue infections or invasive infections in many communities. METHODS: Prospective surveillance for community-acquired S. aureus infections at Texas Children's Hospital was initiated on 1 August 2001. Infections meeting the definition of community-acquired were identified. Demographic and clinical data were collected. Antibiotic susceptibilities, including inducible resistance to macrolide, lincosamide, and streptogramin B (MLSB), were determined in the clinical microbiology laboratory with the methodology of the NCCLS. All data were entered into a computer database. Data were analyzed by chi2 tests. RESULTS: From 1 August 2001 to 31 July 2004, the percentage of community-acquired S. aureus isolates that were methicillin resistant increased from 71.5% (551 of 771 isolates) in year 1 to 76.4% (1193 of 1562 isolates) in year 3 (P = .008). The number of both community-acquired MRSA (CA-MSRA) isolates and community-acquired methicillin-susceptible S. aureus (CA-MSSA) isolates increased yearly, but the rate of increase was greater for the CA-MRSA isolates. Among the CA-MRSA isolates, 2542 (95.6%) were obtained from children with skin and soft-tissue infections, and 117 (4.4%) were obtained from children with invasive infections. Overall, 62% of children with CA-MRSA isolates and 53% of children with CA-MSSA isolates were admitted to the hospital (P = .0001). The rate of clindamycin resistance increased significantly for both CA-MRSA isolates (P = .003) and CA-MSSA isolates (P = .00003) over the 3 years. MLSB inducible resistance was found in 27 (44%) of 62 clindamycin-resistant CA-MSSA isolates, compared with 6 (4.5%) of 132 clindamycin-resistant CA-MRSA isolates (P < .000001). CONCLUSIONS: CA-MRSA isolates account for an increasing percentage and number of infections at Texas Children's Hospital. Clindamycin resistance increased among community-acquired S. aureus isolates. Community surveillance of community-acquired S. aureus infections is critical to determine the appropriate empiric antibiotic treatment for either local or invasive infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard
Wikler, M. A., & Clinical (2012) · Medical Entomology and Zoology · Cited by 895
How Clonal Is Staphylococcus aureus ?
Feil, E. J., Cooper, J. E., Grundmann, H., Robinson, D. A., Enright, M. C., Berendt, T., Peacock, S. J., Smith, J. M., Murphy, M., Spratt, B. G., et al. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.11.3307-3316.2003 · Cited by 618
Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children
Bogaert, D., van Belkum, A., Sluijter, M., Luijendijk, A., de Groot, R., Rümke, H., Verbrugh, H., & Hermans, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16357-5 · Cited by 592
(1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.282.12.1123 · Cited by 574
Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones
Hooper, D. C. (2001) · Clinical Infectious Diseases · doi:10.1086/319370 · Cited by 517
Dufour, P., Gillet, Y., Bes, M., Lina, G., Vandenesch, F., Floret, D., Etienne, J., & Richet, H. (2002) · Clinical Infectious Diseases · doi:10.1086/342576 · Cited by 513
Mart??nez-Aguilar, G., Avalos-Mishaan, A., Hulten, K., Hammerman, W., Mason, E. O., & Kaplan, S. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133044.79130.2a · Cited by 416
Self-citationGonzalez, B. E., Martinez-Aguilar, G., Hulten, K. G., Hammerman, W. A., Coss-Bu, J., Avalos-Mishaan, A., Mason, E. O., & Kaplan, S. L. (2005) · Pediatrics · doi:10.1542/peds.2004-2300 · Cited by 387
Self-citationNaimi, T. S., LeDell, K. H., Boxrud, D. J., Groom, A. V., Steward, C. D., Johnson, S. K., Besser, J. M., O’Boyle, C., Danila, R. N., Cheek, J. E., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322693 · Cited by 369
SATTLER, C. A., MASON, E. O., & KAPLAN, S. L. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00005 · Cited by 332
Self-citationVeenhoven, R., Bogaert, D., Uiterwaal, C., Brouwer, C., Kiezebrink, H., Bruin, J., IJzerman, E., Hermans, P., de Groot, R., Zegers, B., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13772-5 · Cited by 324
MARTÍNEZ-AGUILAR, G., HAMMERMAN, W. A., MASON, E. O., & KAPLAN, S. L. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073163.37519.ee · Cited by 315
Self-citationRegev-Yochay, G. (2004) · JAMA · doi:10.1001/jama.292.6.716 · Cited by 297
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
FRANK, A. L., MARCINAK, J. F., MANGAT, P. D., TJHIO, J. T., KELKAR, S., SCHRECKENBERGER, P. C., & QUINN, J. P. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200206000-00010 · Cited by 271
Bartlett, J. G. (2004) · Infectious Diseases in Clinical Practice · Cited by 266
Diep, B. A., Sensabaugh, G. F., Somboona, N. S., Carleton, H. A., & Perdreau-Remington, F. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2080-2084.2004 · Cited by 257
The Changing Face of Pleural Empyemas in Children: Epidemiology and Management
Schultz, K. D., Fan, L. L., Pinsky, J., Ochoa, L., Smith, E. O., Kaplan, S. L., & Brandt, M. L. (2004) · Pediatrics · doi:10.1542/peds.113.6.1735 · Cited by 232
Self-citationMongkolrattanothai, K., Boyle, S., Kahana, M. D., & Daum, R. S. (2003) · Clinical Infectious Diseases · doi:10.1086/378277 · Cited by 230
Healy, C. M., Hulten, K. G., Palazzi, D. L., Campbell, J. R., & Baker, C. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425321 · Cited by 229
Self-citationLinezolid versus vancomycin for treatment of resistant Gram-positive infections in children
KAPLAN, S. L., DEVILLE, J. G., YOGEV, R., MORFIN, M. R., WU, E., ADLER, S., EDGE-PADBURY, B., NABERHUIS-STEHOUWER, S., & BRUSS, J. B. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000078160.29072.42 · Cited by 191
Self-citationBuckingham, S. C., McDougal, L. K., Cathey, L. D., Comeaux, K., Craig, A. S., Fridkin, S. K., & Tenover, F. C. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000131981.67342.c4 · Cited by 181
Iyer, S., & Jones, D. H. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.12.043 · Cited by 165
Mishaan, A. M. A., Mason, E. O., Martínez‐Aguilar, G., Hammerman, W. A., Propst, J. J., Lupski, J. R., Stankiewicz, P., Kaplan, S. L., & Hultén, K. G. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000151107.29132.70 · Cited by 134
Self-citationPurcell, K., & FERGIE, J. E. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00028 · Cited by 76
Baum, S., Morris, J. T., Dooley, D. P., & Watson, R. (2003) · Military Medicine · doi:10.1093/milmed/168.2.126 · Cited by 14
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Self-citationKlevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Metadata
- Authors
- Kaplan, S. L., Hulten, K. G., Gonzalez, B. E., Hammerman, W. A., Lamberth, L., Versalovic, J., & Mason, E. O.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-15
- Volume
- 40
- Issue
- 12
- Pages
- 1785-1791
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2163686122
- Cited by
- 602
- References
- 30
- FWCI
- 32.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.